Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
weight-loss and diet control industry
weight-loss and diet control industry
Newsletters
Exclusive: The founders of SoulCycle built a startup for relationships, then pivoted to GLP-1 support groups. Now its assets are being acquired by WeightWatchers
By
Crypto Correspondent
August 7, 2025
Aging Well
The key to a long life is avoiding the ‘poisonous 5 P’s,’ says one of the world’s top anti-aging experts
By
Editorial Team
May 24, 2025
Tech
Novo ousts CEO Jorgensen after Lilly competition hits shares
By
Eric Pfanner
and
Bloomberg
May 16, 2025
Health
Zepbound users lost nearly 50% more weight than those on Wegovy in first head-to-head study
By
Jonel Aleccia
and
The Associated Press
May 12, 2025
Health
Currency hedging and new U.S. factories: Novo Nordisk CFO thinks Wegovy maker can outmaneuver global trade wars
By
Research Team
May 9, 2025
Finance
WeightWatchers files for bankruptcy as it struggles for a place in a weight loss world dominated by Ozempic and Wegovy
By
News Correspondent
May 7, 2025
Health
CVS strikes a deal to offer Wegovy at a discount
By
Digital Assets Editor
May 1, 2025
Health
Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers
By
Bloomberg
,
Madison Muller
,
Ike Swetlitz
and
Naomi Kresge
February 21, 2025
Finance
Weight-loss drug Zepbound helped drive Ireland to $76 billion in goods exports to the U.S. last year—a bittersweet reminder of the challenges ahead
By
Editorial Team
February 19, 2025
Health
The dietary supplements you think are improving your health may be damaging your liver, research warns
By
Research Team
February 19, 2025
Health
Ozempic, Wegovy maker calls out Hims & Hers Super Bowl ad: ‘Check before you inject’
By
News Correspondent
February 11, 2025
Health
As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs
By
Digital Assets Editor
February 5, 2025
Health
Investors are growing anxious about Novo Nordisk’s silence since disappointing CagriSema weight loss drug results
By
News Correspondent
February 4, 2025
Health
Hims & Hers Super Bowl ad slams pricey pharma industry—and fumbles FDA warnings on compounded GLP-1 drugs
By
Investment Desk
February 3, 2025
Health
Online searches predicted the surge in prescriptions of weight-loss drugs like Wegovy and Zepbound, study says. Here’s what could happen next
By
Financial Writer
January 29, 2025
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Investment Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Industry Analyst
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Editorial Team